COVID-19 Impact on Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, Status and Forecast 2020-2026

August 2020 | 98 pages | ID: C922577BA313EN
QYResearch

Abstracts

This report focuses on the global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Technologies for Delivery of Proteins, Antibodies and Nucleic Acids development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Aphios
• Arbutus Biopharma
• Camurus
• ConjuChem
• InnoCore Pharmaceuticals
• LATITUDE Pharmaceuticals
• ...

Market segment by Type, the product can be split into

• HEPtune® Technology
• Intravail® Technology
• RapidMist™
• TheraKine Technology
• Arestat™ Technology
• DelSiTech™ Silica Matrix
• ImSus® Technology
• PLEX™ Technology
• ENHANZE® Technology

Market segment by Application, split into

• Delivery of Protein
• Delivery of Nucleic Acids
• Delivery Antibody

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids status, future forecast, growth opportunity, key market and key players.
• To present the Technologies for Delivery of Proteins, Antibodies and Nucleic Acids development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue
1.4 Market Analysis by Type
  1.4.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 HEPtune® Technology
  1.4.3 Intravail® Technology
  1.4.4 RapidMist™
  1.4.5 TheraKine Technology
  1.4.6 Arestat™ Technology
  1.4.7 DelSiTech™ Silica Matrix
  1.4.8 ImSus® Technology
  1.4.9 PLEX™ Technology
  1.4.10 ENHANZE® Technology
1.5 Market by Application
  1.5.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application: 2020 VS 2026
  1.5.2 Delivery of Protein
  1.5.3 Delivery of Nucleic Acids
  1.5.4 Delivery Antibody
1.6 Coronavirus Disease 2019 (Covid-19): Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Industry Impact
  1.6.1 How the Covid-19 is Affecting the Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Industry
    1.6.1.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Perspective (2015-2026)
2.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Growth Trends by Regions
  2.2.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Historic Market Share by Regions (2015-2020)
  2.2.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Growth Strategy
  2.3.6 Primary Interviews with Key Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Market Size
  3.1.1 Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Revenue (2015-2020)
  3.1.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Players (2015-2020)
  3.1.3 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Concentration Ratio
  3.2.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in 2019
3.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players Head office and Area Served
3.4 Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Solution and Service
3.5 Date of Enter into Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Historic Market Size by Type (2015-2020)
4.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Type (2021-2026)

5 TECHNOLOGIES FOR DELIVERY OF PROTEINS, ANTIBODIES AND NUCLEIC ACIDS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020)
5.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2015-2020)
6.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in North America (2019-2020)
6.3 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020)
6.4 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2015-2020)
7.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in Europe (2019-2020)
7.3 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020)
7.4 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020)

8 CHINA

8.1 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2015-2020)
8.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in China (2019-2020)
8.3 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020)
8.4 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2015-2020)
9.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in Japan (2019-2020)
9.3 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020)
9.4 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2015-2020)
10.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020)
10.4 Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020)

11 INDIA

11.1 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2015-2020)
11.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in India (2019-2020)
11.3 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020)
11.4 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2015-2020)
12.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in Central & South America (2019-2020)
12.3 Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020)
12.4 Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Aphios
  13.1.1 Aphios Company Details
  13.1.2 Aphios Business Overview and Its Total Revenue
  13.1.3 Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
  13.1.4 Aphios Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020))
  13.1.5 Aphios Recent Development
13.2 Arbutus Biopharma
  13.2.1 Arbutus Biopharma Company Details
  13.2.2 Arbutus Biopharma Business Overview and Its Total Revenue
  13.2.3 Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
  13.2.4 Arbutus Biopharma Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020)
  13.2.5 Arbutus Biopharma Recent Development
13.3 Camurus
  13.3.1 Camurus Company Details
  13.3.2 Camurus Business Overview and Its Total Revenue
  13.3.3 Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
  13.3.4 Camurus Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020)
  13.3.5 Camurus Recent Development
13.4 ConjuChem
  13.4.1 ConjuChem Company Details
  13.4.2 ConjuChem Business Overview and Its Total Revenue
  13.4.3 ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
  13.4.4 ConjuChem Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020)
  13.4.5 ConjuChem Recent Development
13.5 InnoCore Pharmaceuticals
  13.5.1 InnoCore Pharmaceuticals Company Details
  13.5.2 InnoCore Pharmaceuticals Business Overview and Its Total Revenue
  13.5.3 InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
  13.5.4 InnoCore Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020)
  13.5.5 InnoCore Pharmaceuticals Recent Development
13.6 LATITUDE Pharmaceuticals
  13.6.1 LATITUDE Pharmaceuticals Company Details
  13.6.2 LATITUDE Pharmaceuticals Business Overview and Its Total Revenue
  13.6.3 LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
  13.6.4 LATITUDE Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020)
  13.6.5 LATITUDE Pharmaceuticals Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Market Segments
Table 2. Key Players Covered: Ranking by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue
Table 3. Ranking of Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of HEPtune® Technology
Table 6. Key Players of Intravail® Technology
Table 7. Key Players of RapidMist™
Table 8. Key Players of TheraKine Technology
Table 9. Key Players of Arestat™ Technology
Table 10. Key Players of DelSiTech™ Silica Matrix
Table 11. Key Players of ImSus® Technology
Table 12. Key Players of PLEX™ Technology
Table 13. Key Players of ENHANZE® Technology
Table 14. COVID-19 Impact Global Market: (Four Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Forecast Scenarios)
Table 15. Opportunities and Trends for Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players in the COVID-19 Landscape
Table 16. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 17. Key Regions/Countries Measures against Covid-19 Impact
Table 18. Proposal for Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players to Combat Covid-19 Impact
Table 19. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 20. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Regions (US$ Million): 2020 VS 2026
Table 21. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Regions (2015-2020) (US$ Million)
Table 22. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions (2015-2020)
Table 23. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 24. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions (2021-2026)
Table 25. Market Top Trends
Table 26. Key Drivers: Impact Analysis
Table 27. Key Challenges
Table 28. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Growth Strategy
Table 29. Main Points Interviewed from Key Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players
Table 30. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Players (2015-2020) (Million US$)
Table 31. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Players (2015-2020)
Table 32. Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids as of 2019)
Table 33. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids by Players Market Concentration Ratio (CR5 and HHI)
Table 34. Key Players Headquarters and Area Served
Table 35. Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Solution and Service
Table 36. Date of Enter into Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) (Million US$)
Table 39. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Share by Type (2015-2020)
Table 40. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Type (2021-2026)
Table 41. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Share by Application (2015-2020)
Table 42. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) (Million US$)
Table 43. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Share by Application (2021-2026)
Table 44. North America Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (2019-2020) (Million US$)
Table 45. North America Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share (2019-2020)
Table 46. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) (Million US$)
Table 47. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2015-2020)
Table 48. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) (Million US$)
Table 49. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2015-2020)
Table 50. Europe Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (2019-2020) (Million US$)
Table 51. Europe Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share (2019-2020)
Table 52. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) (Million US$)
Table 53. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2015-2020)
Table 54. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) (Million US$)
Table 55. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2015-2020)
Table 56. China Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (2019-2020) (Million US$)
Table 57. China Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share (2019-2020)
Table 58. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) (Million US$)
Table 59. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2015-2020)
Table 60. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) (Million US$)
Table 61. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2015-2020)
Table 62. Japan Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (2019-2020) (Million US$)
Table 63. Japan Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share (2019-2020)
Table 64. Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) (Million US$)
Table 65. Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2015-2020)
Table 66. Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) (Million US$)
Table 67. Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2015-2020)
Table 68. Southeast Asia Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (2019-2020) (Million US$)
Table 69. Southeast Asia Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share (2019-2020)
Table 70. Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) (Million US$)
Table 71. Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2015-2020)
Table 72. Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) (Million US$)
Table 73. Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2015-2020)
Table 74. India Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (2019-2020) (Million US$)
Table 75. India Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share (2019-2020)
Table 76. India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) (Million US$)
Table 77. India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2015-2020)
Table 78. India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) (Million US$)
Table 79. India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2015-2020)
Table 80. Central & South America Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (2019-2020) (Million US$)
Table 81. Central & South America Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share (2019-2020)
Table 82. Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) (Million US$)
Table 83. Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2015-2020)
Table 84. Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) (Million US$)
Table 85. Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2015-2020)
Table 86. Aphios Company Details
Table 87. Aphios Business Overview
Table 88. Aphios Product
Table 89. Aphios Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) (Million US$)
Table 90. Aphios Recent Development
Table 91. Arbutus Biopharma Company Details
Table 92. Arbutus Biopharma Business Overview
Table 93. Arbutus Biopharma Product
Table 94. Arbutus Biopharma Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) (Million US$)
Table 95. Arbutus Biopharma Recent Development
Table 96. Camurus Company Details
Table 97. Camurus Business Overview
Table 98. Camurus Product
Table 99. Camurus Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) (Million US$)
Table 100. Camurus Recent Development
Table 101. ConjuChem Company Details
Table 102. ConjuChem Business Overview
Table 103. ConjuChem Product
Table 104. ConjuChem Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) (Million US$)
Table 105. ConjuChem Recent Development
Table 106. InnoCore Pharmaceuticals Company Details
Table 107. InnoCore Pharmaceuticals Business Overview
Table 108. InnoCore Pharmaceuticals Product
Table 109. InnoCore Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) (Million US$)
Table 110. InnoCore Pharmaceuticals Recent Development
Table 111. LATITUDE Pharmaceuticals Company Details
Table 112. LATITUDE Pharmaceuticals Business Overview
Table 113. LATITUDE Pharmaceuticals Product
Table 114. LATITUDE Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) (Million US$)
Table 115. LATITUDE Pharmaceuticals Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type: 2020 VS 2026
Figure 2. HEPtune® Technology Features
Figure 3. Intravail® Technology Features
Figure 4. RapidMist™ Features
Figure 5. TheraKine Technology Features
Figure 6. Arestat™ Technology Features
Figure 7. DelSiTech™ Silica Matrix Features
Figure 8. ImSus® Technology Features
Figure 9. PLEX™ Technology Features
Figure 10. ENHANZE® Technology Features
Figure 11. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application: 2020 VS 2026
Figure 12. Delivery of Protein Case Studies
Figure 13. Delivery of Nucleic Acids Case Studies
Figure 14. Delivery Antibody Case Studies
Figure 15. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Report Years Considered
Figure 16. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions: 2020 VS 2026
Figure 18. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Players in 2019
Figure 21. Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in 2019
Figure 23. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Aphios Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Aphios Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020)
Figure 32. Arbutus Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Arbutus Biopharma Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020)
Figure 34. Camurus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Camurus Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020)
Figure 36. ConjuChem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. ConjuChem Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020)
Figure 38. InnoCore Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. InnoCore Pharmaceuticals Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020)
Figure 40. LATITUDE Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. LATITUDE Pharmaceuticals Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed